H2S‑Powered Nanomotors for Active Therapy of Tumors by Inducing Ferroptosis and Lactate-Pyruvate Axis Disorders
ACS Biomaterials Science & Engineering · 2024
DOI: 10.1021/acsbiomaterials.3c01665 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Biomaterials Science & Engineering, 2024. Verfasst von Weixin Wang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, Binzhou Medical University, Yantai, 264003, PR China. Hauptthemen laut MEDLINE: Ferroptosis, Lactic Acid, Pyruvic Acid, Tumor Microenvironment. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Binzhou Medical University, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
Disruption of the symbiosis of extra/intratumoral metabolism is a good strategy for treating tumors that shuttle resources from the tumor microenvironment. Here, we report a precision treatment strategy for enhancing pyruvic acid and intratumoral acidosis to destroy tumoral metabolic symbiosis to eliminate tumors; this approach is based on PEGylated gold and lactate oxidase-modified aminated dendritic mesoporous silica with lonidamine and ferrous sulfide loading (PEG-Au@DMSNs/FeS/LND@LOX). In the tumor microenvironment, LOX oxidizes lactic acid to produce pyruvate, which represses tumor cell proliferation by inhibiting histone gene expression and induces ferroptosis by partial histone monoubiquitination. In acidic tumor conditions, the nanoparticles release H2S gas and Fe2+ ions, which can inhibit catalase activity to promote the Fenton reaction of Fe2+, resulting in massive ·OH production and ferroptosis via Fe3+. More interestingly, the combination of H2S and LND (a monocarboxylic acid transporter inhibitor) can cause intracellular acidosis by lactate, and protons overaccumulate in cells. Multiple intracellular acidosis is caused by lactate-pyruvate axis disorders. Moreover, H2S provides motive power to intensify the shuttling of nanoparticles in the tumor region. The findings confirm that this nanomedicine system can enable precise antitumor effects by disrupting extra/intratumoral metabolic symbiosis and inducing ferroptosis and represents a promising active drug delivery system candidate for tumor treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, School of Pharmacy, Binzhou Medical University, Yantai, 264003, PR China.
- Key Laboratory of Tropical Biological Resources of Ministry of Education and One Health Institute, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, China.
- Institute of Molecular Medicine (IMM), Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200240, China.
- Institute of Cardiovascular Disease, Shanxi Medical University, Taiyuan, 030001, PR China.
- Xi'an Medical University, Xi'an, 710000, PR China.
- Clinical Medical College, Binzhou Medical University, Yantai, 264003, PR China.
ORCID-Profile: Fei Tong
Förderung
- Binzhou Medical University
- Natural Science Foundation of Shandong Province
Zitieren
APA
Wang, W., Fu, R., Gao, R., Luo, L., Wang, Z., Xue, Y., Sun, J., Pan, M., Hong, M., Qiao, L., Qiao, W., Mei, Q., Wu, J., Wang, Y., Zhong, Y., Liu, J., & Tong, F. (2024). H2S‑Powered Nanomotors for Active Therapy of Tumors by Inducing Ferroptosis and Lactate-Pyruvate Axis Disorders. ACS Biomaterials Science & Engineering. https://doi.org/10.1021/acsbiomaterials.3c01665
Vancouver
Wang W, Fu R, Gao R, Luo L, Wang Z, Xue Y, et al. H2S‑Powered Nanomotors for Active Therapy of Tumors by Inducing Ferroptosis and Lactate-Pyruvate Axis Disorders. ACS Biomaterials Science & Engineering. 2024. doi:10.1021/acsbiomaterials.3c01665
BibTeX
@article{Wang2024,
author = {Wang, Weixin and Fu, Renquan and Gao, Rui and Luo, Lei and Wang, Zhongchao and Xue, Yingli and Sun, Jiahui and Pan, Min and Hong, Miaofang and Qiao, Lingyan and Qiao, Weiwei and Mei, Qibing and Wu, Jianming and Wang, Yini and Zhong, Yali and Liu, Jin and Tong, Fei},
title = {H2S‑Powered Nanomotors for Active Therapy of Tumors by Inducing Ferroptosis and Lactate-Pyruvate Axis Disorders},
journal = {ACS Biomaterials Science & Engineering},
year = {2024},
doi = {10.1021/acsbiomaterials.3c01665}
}
EUVIMED